NCT03149042

Brief Summary

Coronary Computed Tomography Angiography (CCTA) contrast opacification gradients and FFR-CT estimation can aid in the severity estimation of significant atherosclerotic lesions. Currently, FFR-CT algorithms can only be optimized using theoretical models and can only be validated in large multi-center clinical trials. Using patient specific 3D printed coronary phantoms would allow optimization of FFR-CT algorithms with a measured validation technique without the need for large clinical trials. Thus the investigators believe that this study will result in a FFR-CT algorithm/method with a better predictability for arterial lesion severity than those existing on the market today. Flow measurements will be compared with: CT-FFR for both patients and phantoms, angio lab FFR measurements and 30 days follow-up. This pilot clinical study includes \~50 patients over a year and half at GVI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 28, 2016

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 11, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 23, 2020

Completed
Last Updated

November 17, 2020

Status Verified

November 1, 2020

Enrollment Period

2.6 years

First QC Date

May 8, 2017

Results QC Date

May 4, 2020

Last Update Submit

November 15, 2020

Conditions

Keywords

FFRFractional Flow ReserveAtherosclerosisCoronarystenosis

Outcome Measures

Primary Outcomes (4)

  • Comparison of CT Based FFR With Invasive FFR, ROC Analysis

    Patient CCTA images were imported into Vitrea segmentation software (Vital Images, Minnetonka, MN) for use in the research-based CT based FFR algorithm. The software analyzes four data volumes acquired a 70%, 80%, 90% and 99% of the R-R interval and computes the FFR based on the changes in vessel diameter and computational fluid dynamics. Within the algorithm, the aortic root and three main coronary arteries (LAD, LCX, and RCA) were automatically segmented, and then manually adjusted to obtain accurate centerline and contours. The CT based FFR was calculated and the user adjusted the location of the distal pressure measurement to calculate the CT basedFFR at the same location as Invasive-FFR, two lesion lengths below the distal end of the lesion. Area under the Receiver Operator Characteristic were measured where an Invasive FFR\<=0.8 was considered positive.

    24 hours

  • Comparison of CT Based FFR With Invasive FFR, Correlation Analysis

    Patient CCTA images were imported into Vitrea segmentation software (Vital Images, Minnetonka, MN) for use in the research-based CT based FFR algorithm. The software analyzes four data volumes acquired a 70%, 80%, 90% and 99% of the R-R interval and computes the FFR based on the changes in vessel diameter and computational fluid dynamics. Within the algorithm, the aortic root and three main coronary arteries (LAD, LCX, and RCA) were automatically segmented, and then manually adjusted to obtain accurate centerline and contours. The CT based FFR was calculated and the user adjusted the location of the distal pressure measurement to calculate the CT basedFFR at the same location as Invasive-FFR, two lesion lengths below the distal end of the lesion. Pearson Correlation between Invasive FFR and CT based FFR was measured

    24 hours

  • Comparison of CT Based FFR With Invasive FFR, Sensitivity

    Patient CCTA images were imported into Vitrea segmentation software (Vital Images, Minnetonka, MN) for use in the research-based CT based FFR algorithm. The software analyzes four data volumes acquired a 70%, 80%, 90% and 99% of the R-R interval and computes the FFR based on the changes in vessel diameter and computational fluid dynamics. Within the algorithm, the aortic root and three main coronary arteries (LAD, LCX, and RCA) were automatically segmented, and then manually adjusted to obtain accurate centerline and contours. The CT based FFR was calculated and the user adjusted the location of the distal pressure measurement to calculate the CT basedFFR at the same location as Invasive-FFR, two lesion lengths below the distal end of the lesion. Sensitivity were measured where an Invasive FFR\<=0.8 was considered positive. Sensitivity reflects the percentage of true positive cases identified by CT-FFR compared to I-FFR

    24 hours

  • Comparison of CT Based FFR With Invasive FFR, Specificity

    Patient CCTA images were imported into Vitrea segmentation software (Vital Images, Minnetonka, MN) for use in the research-based CT based FFR algorithm. The software analyzes four data volumes acquired a 70%, 80%, 90% and 99% of the R-R interval and computes the FFR based on the changes in vessel diameter and computational fluid dynamics. Within the algorithm, the aortic root and three main coronary arteries (LAD, LCX, and RCA) were automatically segmented, and then manually adjusted to obtain accurate centerline and contours. The CT based FFR was calculated and the user adjusted the location of the distal pressure measurement to calculate the CT basedFFR at the same location as Invasive-FFR, two lesion lengths below the distal end of the lesion. Specificity was measured, where an Invasive FFR\<=0.8 was considered positive. Specificity reflects the percentage of true negative cases identified by CT-FFR compared to I-FFR

    24 hours

Secondary Outcomes (5)

  • Comparison of CT Based FFR With Bench-top FFR Using 3D Printed Patient Specific Phantoms

    4 weeks from baseline

  • Comparison of Bench-top FFR Using 3D Printed Patient Specific Phantoms With Invasive FFR, ROC Analysis

    4 weeks from baseline

  • Comparison of Bench-top FFR Using 3D Printed Patient Specific Phantoms With Invasive FFR, Pearson Correlation

    4 weeks from baseline

  • Comparison of Bench-top FFR Using 3D Printed Patient Specific Phantoms With Invasive FFR, Sensitivity

    4 weeks from baseline

  • Comparison of Bench-top FFR Using 3D Printed Patient Specific Phantoms With Invasive FFR, Specificity

    4 weeks from baseline

Study Arms (1)

CCTA

Patients who are scheduled for clinically mandated elective invasive coronary angiography (ICA) at Buffalo General Hospital.

Diagnostic Test: CCTA

Interventions

CCTADIAGNOSTIC_TEST

Diagnostic Test

CCTA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are (1) scheduled for clinically mandated elective invasive coronary angiography (ICA) at Buffalo General Hospital or Juntendo Hospital Japan (2) clinically mandated CTA will be screened.

You may qualify if:

  • All the patients \>18 yrs of age , who are undergoing CCTA and angio-FFR. Patients who are (1) scheduled for clinically mandated elective invasive coronary angiography (ICA) at Buffalo General Hospital or (2) clinically mandated CTA will be screened.

You may not qualify if:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • atrial fibrillation,
  • Renal insufficiency (estimated glomerular filtration rate (GFR) \<60 ml/min/1.73 m2),
  • Active Bronchospasm prohibiting the use of beta blockers
  • Morbid obesity (body mass index 40 kg/m2)
  • Contraindications to iodinated contrast.
  • Emergencies requiring immediate intervention or patients unable to consent.
  • Patients not showing coronary calcium during Calcium Scoring procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical and Translational Research Center Room 8052

Buffalo, New York, 14021, United States

Location

Related Publications (9)

  • Sommer K, Izzo RL, Shepard L, Podgorsak AR, Rudin S, Siddiqui AH, Wilson MF, Angel E, Said Z, Springer M, Ionita CN. Design Optimization for Accurate Flow Simulations in 3D Printed Vascular Phantoms Derived from Computed Tomography Angiography. Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10138:101380R. doi: 10.1117/12.2253711. Epub 2017 Mar 13.

    PMID: 28663663BACKGROUND
  • Ionita, C., Angel, E., Mitsouras, D., Rudin, S., Bednarek, D., Zaid, S., Wilson, M. and Rybicki, F. (2016), TU-H-CAMPUS-IeP2-03: Development of 3D Printed Coronary Phantoms for In-Vitro CT-FFR Validation Using Data from 320- Detector Row Coronary CT Angiography. Med. Phys., 43: 3781. doi:10.1118/1.4957681

    BACKGROUND
  • Kelsey N. Sommer, Lauren M. Shepard, Vijay Iyer, Erin Angel, Michael F. Wilson, Frank J. Rybicki, Dimitrios Mitsouras, Kanako Kunishima Kumamaru, Stephen Rudin, and Ciprian N. Ionita. Comparison of benchtop pressure gradient measurements in 3D printed patient specific cardiac phantoms with CT-FFR and computational fluid dynamic simulations, Proc. SPIE 10953, Medical Imaging 2019: Biomedical Applications in Molecular, Structural, and Functional Imaging, 109531P (15 March 2019);

    BACKGROUND
  • Shepard LM, Sommer KN, Angel E, Iyer V, Wilson MF, Rybicki FJ, Mitsouras D, Molloi S, Ionita CN. Initial evaluation of three-dimensionally printed patient-specific coronary phantoms for CT-FFR software validation. J Med Imaging (Bellingham). 2019 Apr;6(2):021603. doi: 10.1117/1.JMI.6.2.021603. Epub 2019 Mar 12.

    PMID: 30891468BACKGROUND
  • Sommer KN, Shepard L, Karkhanis NV, Iyer V, Angel E, Wilson MF, Rybicki FJ, Mitsouras D, Rudin S, Ionita CN. 3D Printed Cardiovascular Patient Specific Phantoms Used for Clinical Validation of a CT-derived FFR Diagnostic Software. Proc SPIE Int Soc Opt Eng. 2018 Feb;10578:105780J. doi: 10.1117/12.2292736. Epub 2018 Mar 12.

    PMID: 29899591BACKGROUND
  • Shepard L, Sommer K, Izzo R, Podgorsak A, Wilson M, Said Z, Rybicki FJ, Mitsouras D, Rudin S, Angel E, Ionita CN. Initial Simulated FFR Investigation Using Flow Measurements in Patient-specific 3D Printed Coronary Phantoms. Proc SPIE Int Soc Opt Eng. 2017 Feb 11;10138:101380S. doi: 10.1117/12.2253889. Epub 2017 Mar 13.

    PMID: 28649159BACKGROUND
  • Kelsey N. Sommer, Lauren M. Shepard, Vijay Iyer, Erin Angel, Michael F. Wilson, Frank J. Rybicki, Dimitrios Mitsouras, Ciprian Ionita. Study of the effect of boundary conditions on fractional flow reserve using patient specific coronary phantoms. Proceedings Volume 11317, Medical Imaging 2020: Biomedical Applications in Molecular, Structural, and Functional Imaging; 113171J (2020) https://doi.org/10.1117/12.2548472

    BACKGROUND
  • Sommer KN, Shepard LM, Mitsouras D, Iyer V, Angel E, Wilson MF, Rybicki FJ, Kumamaru KK, Sharma UC, Reddy A, Fujimoto S, Ionita CN. Patient-specific 3D-printed coronary models based on coronary computed tomography angiography volumes to investigate flow conditions in coronary artery disease. Biomed Phys Eng Express. 2020 May 14;6(4):045007. doi: 10.1088/2057-1976/ab8f6e.

  • Kumamaru KK, Angel E, Sommer KN, Iyer V, Wilson MF, Agrawal N, Bhardwaj A, Kattel SB, Kondziela S, Malhotra S, Manion C, Pogorzelski K, Ramanan T, Sawant AC, Suplicki MM, Waheed S, Fujimoto S, Sharma UC, Rybicki FJ, Ionita CN. Inter- and Intraoperator Variability in Measurement of On-Site CT-derived Fractional Flow Reserve Based on Structural and Fluid Analysis: A Comprehensive Analysis. Radiol Cardiothorac Imaging. 2019 Aug 29;1(3):e180012. doi: 10.1148/ryct.2019180012. eCollection 2019 Aug.

Related Links

MeSH Terms

Conditions

Coronary Artery DiseaseAtherosclerosisConstriction, Pathologic

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Limitations and Caveats

Operators were not blinded to the invasive-FFR results at the time of calculating the CT based FFR and Bench-top measurements

Results Point of Contact

Title
Dr. Ciprian Ionita
Organization
University at Buffalo

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 8, 2017

First Posted

May 11, 2017

Study Start

May 28, 2016

Primary Completion

December 31, 2018

Study Completion

April 21, 2019

Last Updated

November 17, 2020

Results First Posted

June 23, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations